Published in BMC Nephrol on February 22, 2013
Recurrent focal segmental glomerulosclerosis after kidney transplantation. Pediatr Nephrol (2015) 1.73
Soluble Urokinase Receptors in Focal Segmental Glomerulosclerosis: A Review on the Scientific Point of View. J Immunol Res (2016) 0.87
Minimal change disease and idiopathic FSGS: manifestations of the same disease. Nat Rev Nephrol (2016) 0.77
Recurrence and Treatment after Renal Transplantation in Children with FSGS. Biomed Res Int (2016) 0.75
Actualizing the Benefits of Genomic Discovery in Pediatric Nephrology. J Pediatr Genet (2015) 0.75
Thrombotic Microangiopathy in Inverted Formin 2-Mediated Renal Disease. J Am Soc Nephrol (2016) 0.75
Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol (2003) 18.01
Multiple imputation using chained equations: Issues and guidance for practice. Stat Med (2010) 17.36
Using the outcome for imputation of missing predictor values was preferred. J Clin Epidemiol (2006) 7.83
The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents. Pediatr Clin North Am (1987) 7.63
Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med (1996) 4.41
Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol (2006) 3.28
Recurrence of nephrotic syndrome in kidney grafts of patients with congenital nephrotic syndrome of the Finnish type: role of nephrin. Transplantation (2002) 1.83
Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int (2012) 1.55
Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation (2009) 1.47
Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol (1990) 1.44
Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol Dial Transplant (2012) 1.29
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation (1999) 1.27
Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med (1992) 1.24
Recurrence of focal segmental glomerular sclerosis (FSGS) after renal transplantation. Nephrol Dial Transplant (2009) 1.24
Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant (2005) 1.11
Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant (2009) 1.11
Fidelity and evolution of recurrent FSGS in renal allografts. J Am Soc Nephrol (2008) 1.11
Disease recurrence in paediatric renal transplantation. Pediatr Nephrol (2009) 1.10
Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis (1999) 1.09
Early recurrent nephrotic syndrome after renal transplantation in children with focal segmental glomerulosclerosis. Nephrol Dial Transplant (2000) 1.06
High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children. Am J Kidney Dis (2004) 1.06
Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol (2010) 1.03
Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children. Transplantation (2003) 1.02
Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis (2001) 1.00
The recurrence of focal segmental glomerulosclerosis in kidney transplant patients treated with cyclosporine. Transplantation (1990) 0.93
Review on diagnosis and treatment of focal segmental glomerulosclerosis. Neth J Med (2008) 0.92
Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejection. Kidney Int (1994) 0.92
Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience. Transplantation (1991) 0.92
Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function. Clin Transplant (2009) 0.92
Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl Int (2004) 0.90
Recurrent glomerulonephritis in the renal allograft: an update of selected areas. Exp Clin Transplant (2005) 0.89
Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation (1981) 0.89
The influence of native nephrectomy on the incidence of recurrent disease following renal transplantation for primary glomerulonephritis. Transplantation (1996) 0.88
Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis. Transplant Proc (2006) 0.86
Multicentric carpal-tarsal osteolysis with nephropathy treated successfully with cyclosporine A: a case report and literature review. Am J Kidney Dis (2007) 0.84
'Idiopathic' FSGS: an increasingly obsolete diagnosis? Nephrol Dial Transplant (2010) 0.82
Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression. Clin Nephrol (2010) 0.82
Long-term outcome of renal transplantation in adults with focal segmental glomerulosclerosis. Transpl Int (2009) 0.82
Recurrent focal segmental glomerulosclerosis after renal transplantation: is early recurrent proteinuria always a surrogate marker for recurrence of the disease? Transplant Proc (2002) 0.77
Glomerular albumin permeability as an in vitro model for characterizing the mechanism of focal glomerulosclerosis and predicting post-transplant recurrence. Pediatr Transplant (2004) 0.77
Age and association of kidney measures with mortality and end-stage renal disease. JAMA (2012) 7.20
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med (2011) 6.34
Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology (2012) 3.52
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol (2009) 2.84
Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. Clin J Am Soc Nephrol (2009) 2.12
Proximal tubular cells contain a phenotypically distinct, scattered cell population involved in tubular regeneration. J Pathol (2013) 2.12
Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. J Am Soc Nephrol (2013) 1.94
Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome. J Am Soc Nephrol (2013) 1.90
Tracing the origin of glomerular extracapillary lesions from parietal epithelial cells. J Am Soc Nephrol (2009) 1.85
Parietal epithelial cells participate in the formation of sclerotic lesions in focal segmental glomerulosclerosis. J Am Soc Nephrol (2011) 1.80
Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood (2011) 1.79
Macroalbuminuria is a better risk marker than low estimated GFR to identify individuals at risk for accelerated GFR loss in population screening. J Am Soc Nephrol (2006) 1.78
Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant (2002) 1.74
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders. Clin Chem (2010) 1.68
Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2012) 1.64
C14ORF179 encoding IFT43 is mutated in Sensenbrenner syndrome. J Med Genet (2011) 1.58
Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet (2010) 1.57
Idiopathic membranous nephropathy: outline and rationale of a treatment strategy. Am J Kidney Dis (2005) 1.56
Serum-soluble urokinase receptor concentration in primary FSGS. Kidney Int (2012) 1.55
Comparison of three methods for isolation of urinary microvesicles to identify biomarkers of nephrotic syndrome. Kidney Int (2010) 1.52
Validation of the kidney failure risk equation in European CKD patients. Nephrol Dial Transplant (2013) 1.48
Renal toxicity of radiolabeled peptides and antibody fragments: mechanisms, impact on radionuclide therapy, and strategies for prevention. J Nucl Med (2010) 1.46
Serum creatinine is a poor marker of GFR in nephrotic syndrome. Nephrol Dial Transplant (2005) 1.42
Abnormal vitamin D metabolism and loss of bone mass after renal transplantation. Nephron Clin Pract (2003) 1.39
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. J Nucl Med (2006) 1.37
Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin. J Nucl Med (2006) 1.34
Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 1.30
MASTERPLAN: study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients. J Nephrol (2008) 1.30
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway. Am J Pathol (2011) 1.30
Genetic causes of focal segmental glomerulosclerosis: implications for clinical practice. Nephrol Dial Transplant (2012) 1.29
Alkylating agents in membranous nephropathy: efficacy proven beyond doubt. Nephrol Dial Transplant (2010) 1.28
Multifactorial intervention with nurse practitioners does not change cardiovascular outcomes in patients with chronic kidney disease. Kidney Int (2012) 1.24
Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate. Nephrol Dial Transplant (2009) 1.22
Pathological variants of focal segmental glomerulosclerosis in an adult Dutch population--epidemiology and outcome. Nephrol Dial Transplant (2007) 1.17
Management of patients with membranous nephropathy. Nephrol Dial Transplant (2011) 1.17
Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis. Kidney Int (2008) 1.14
Serum suPAR in patients with FSGS: trash or treasure? Pediatr Nephrol (2013) 1.13
The parietal epithelial cell: a key player in the pathogenesis of focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. J Am Soc Nephrol (2004) 1.12
High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Nephrol Dial Transplant (2011) 1.12
Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int (2009) 1.11
Introduction of a cyclophosphamide-based treatment strategy and the risk of ESRD in patients with idiopathic membranous nephropathy: a nationwide survey in the Netherlands. Nephrol Dial Transplant (2008) 1.10
Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Nephrol Dial Transplant (2008) 1.10
Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial. Nephrol Dial Transplant (2009) 1.09
Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant (2008) 1.07
Initial implementation of a web-based consultation process for patients with chronic kidney disease. Ann Fam Med (2013) 1.07
Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol (2013) 1.07
Incidence of late vitamin K deficiency bleeding in newborns in the Netherlands in 2005: evaluation of the current guideline. Eur J Pediatr (2007) 1.05
Reducing renal uptake of radiolabeled peptides using albumin fragments. J Nucl Med (2008) 1.05
Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy. Nephrol Dial Transplant (2008) 1.04
Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Nephrol Dial Transplant (2007) 1.02
Membranous nephropathy in the older adult: epidemiology, diagnosis and management. Drugs Aging (2007) 1.01
Long-term treatment with tenofovir: prevalence of kidney tubular dysfunction and its association with tenofovir plasma concentration. Antivir Ther (2014) 1.00
Small increases in the urinary excretion of glutathione S-transferase A1 and P1 after cardiac surgery are not associated with clinically relevant renal injury. Intensive Care Med (2005) 1.00
Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol (2002) 1.00
Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate. Nephrol Dial Transplant (2004) 0.99
Uremic toxins inhibit transport by breast cancer resistance protein and multidrug resistance protein 4 at clinically relevant concentrations. PLoS One (2011) 0.99
Introduction of the CKD-EPI equation to estimate glomerular filtration rate in a Caucasian population. Nephrol Dial Transplant (2011) 0.99
Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome? Nephrol Dial Transplant (2007) 0.97
Long-term outcomes in idiopathic membranous nephropathy using a restrictive treatment strategy. J Am Soc Nephrol (2013) 0.95
The clinician and estimation of glomerular filtration rate by creatinine-based formulas: current limitations and quo vadis. Clin J Am Soc Nephrol (2011) 0.95
Fibroblast growth factor 23 is associated with proteinuria and smoking in chronic kidney disease: an analysis of the MASTERPLAN cohort. BMC Nephrol (2012) 0.95
Renal transplantation in patients with hemolytic uremic syndrome: high rate of recurrence and increased incidence of acute rejections. Transplantation (2003) 0.95
Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis (2007) 0.95
In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac. Am J Physiol Renal Physiol (2012) 0.94
Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrol Dial Transplant (2012) 0.93
Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques. BMC Nephrol (2012) 0.93
Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS One (2012) 0.92
Nurse practitioner care improves renal outcome in patients with CKD. J Am Soc Nephrol (2013) 0.92
Antibody-induced albuminuria and accelerated focal glomerulosclerosis in the Thy-1.1 transgenic mouse. Kidney Int (2002) 0.90
Plasma exchange improves graft survival in patients with recurrent focal glomerulosclerosis after renal transplant. Transpl Int (2004) 0.90
Tubular reabsorption and local production of urine hepcidin-25. BMC Nephrol (2013) 0.87
Lithium reduces aquaporin-2 transcription independent of prostaglandins. Am J Physiol Cell Physiol (2011) 0.87
Rationale and design of the MASTERPLAN study: Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol (2005) 0.86
Immunosuppressive treatment of focal segmental glomerulosclerosis: lessons from a randomized controlled trial. Kidney Int (2011) 0.86
Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes. J Am Soc Nephrol (2011) 0.85
Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients. PLoS One (2013) 0.85
Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency. Nephrol Dial Transplant (2005) 0.85
Transition to the adult nephrologist does not induce acute renal transplant rejection. Nephrol Dial Transplant (2009) 0.85
Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy. Nephrol Dial Transplant (2004) 0.85
Estimated glomerular filtration rate in the nephrotic syndrome. Nephrol Dial Transplant (2010) 0.85
Expression of sialidase and dystroglycan in human glomerular diseases. Nephrol Dial Transplant (2009) 0.84
Angiotensin converting enzyme inhibition prevents development of collapsing focal segmental glomerulosclerosis in Thy-1.1 transgenic mice. Nephrol Dial Transplant (2006) 0.84
Podocyte changes upon induction of albuminuria in Thy-1.1 transgenic mice. Nephrol Dial Transplant (2003) 0.84
Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR. Nephrol Dial Transplant (2006) 0.84
Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Nephrol Dial Transplant (2007) 0.84
Proteomic profiling and identification in peritoneal fluid of children treated by peritoneal dialysis. Nephrol Dial Transplant (2008) 0.83